Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 47.93
(-0.15%)
CNY 47.93
(-0.15%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.7 Billion CNY | -1.84% |
| 2022 | 3.78 Billion CNY | 28.4% |
| 2021 | 2.94 Billion CNY | 113.09% |
| 2020 | 1.38 Billion CNY | 72.8% |
| 2019 | 800.65 Million CNY | 54.57% |
| 2018 | 518 Million CNY | 55.39% |
| 2017 | 333.34 Million CNY | 30.13% |
| 2016 | 256.15 Million CNY | 6.99% |
| 2015 | 239.42 Million CNY | 37.77% |
| 2014 | 173.78 Million CNY | 3.24% |
| 2013 | 168.32 Million CNY | 129.3% |
| 2012 | 73.41 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 743.03 Million CNY | -17.92% |
| 2024 Q2 | 914.07 Million CNY | 24.83% |
| 2024 Q1 | 732.27 Million CNY | -41.69% |
| 2023 FY | 3.71 Billion CNY | -1.84% |
| 2023 Q2 | 1.04 Billion CNY | 43.67% |
| 2023 Q1 | 724.71 Million CNY | -41.54% |
| 2023 Q3 | 719.55 Million CNY | -30.89% |
| 2023 Q4 | 1.25 Billion CNY | 74.52% |
| 2022 Q2 | 986.29 Million CNY | 36.62% |
| 2022 Q4 | 1.23 Billion CNY | 48.03% |
| 2022 FY | 3.78 Billion CNY | 28.4% |
| 2022 Q3 | 837.47 Million CNY | -15.09% |
| 2022 Q1 | 721.9 Million CNY | -41.53% |
| 2021 Q3 | 605.57 Million CNY | -11.66% |
| 2021 FY | 2.94 Billion CNY | 113.09% |
| 2021 Q1 | 422.28 Million CNY | -26.79% |
| 2021 Q2 | 685.51 Million CNY | 62.33% |
| 2021 Q4 | 1.23 Billion CNY | 103.89% |
| 2020 Q3 | 321.87 Million CNY | -0.69% |
| 2020 Q1 | 160.72 Million CNY | -42.55% |
| 2020 Q2 | 324.09 Million CNY | 101.65% |
| 2020 FY | 1.38 Billion CNY | 72.8% |
| 2020 Q4 | 576.8 Million CNY | 79.2% |
| 2019 Q1 | 138.96 Million CNY | -33.84% |
| 2019 Q3 | 197.14 Million CNY | 6.7% |
| 2019 FY | 800.65 Million CNY | 54.57% |
| 2019 Q4 | 279.77 Million CNY | 41.92% |
| 2019 Q2 | 184.76 Million CNY | 32.96% |
| 2018 FY | 518 Million CNY | 55.39% |
| 2018 Q4 | 210.04 Million CNY | 76.89% |
| 2018 Q3 | 118.73 Million CNY | -0.05% |
| 2018 Q2 | 118.8 Million CNY | 16.0% |
| 2018 Q1 | 102.41 Million CNY | 0.0% |
| 2017 Q2 | 73.16 Million CNY | 0.0% |
| 2017 Q1 | 73.16 Million CNY | 2.06% |
| 2017 FY | 333.34 Million CNY | 30.13% |
| 2016 Q4 | 71.68 Million CNY | 0.0% |
| 2016 Q2 | 64.77 Million CNY | 0.0% |
| 2016 FY | 256.15 Million CNY | 6.99% |
| 2016 Q3 | 71.68 Million CNY | 10.68% |
| 2016 Q1 | 64.77 Million CNY | -7.75% |
| 2015 Q4 | 70.21 Million CNY | 0.0% |
| 2015 FY | 239.42 Million CNY | 37.77% |
| 2015 Q3 | 70.21 Million CNY | 40.67% |
| 2015 Q2 | 49.91 Million CNY | 0.0% |
| 2015 Q1 | 49.91 Million CNY | 7.08% |
| 2014 Q1 | 40.28 Million CNY | -30.3% |
| 2014 Q3 | 46.61 Million CNY | 15.72% |
| 2014 FY | 173.78 Million CNY | 3.24% |
| 2014 Q4 | 46.61 Million CNY | 0.0% |
| 2014 Q2 | 40.28 Million CNY | 0.0% |
| 2013 Q2 | 26.37 Million CNY | 0.0% |
| 2013 Q3 | 57.78 Million CNY | 119.1% |
| 2013 Q4 | 57.78 Million CNY | 0.0% |
| 2013 FY | 168.32 Million CNY | 129.3% |
| 2013 Q1 | 26.37 Million CNY | 16.09% |
| 2012 FY | 73.41 Million CNY | 0.0% |
| 2012 Q4 | 22.71 Million CNY | 0.0% |
| 2012 Q3 | 22.71 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |